

(Alliance News) - AstraZeneca PLC on Thursday said phase 3 data regarding its investigational inhibitor gefurulimab met its primary endpoint in myasth...


(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they began new phase 3 clinical trial testing of an intravenous treatment f...


(Alliance News) - AstraZeneca PLC on Tuesday said Alexion's selective inhibitor Koseluga has been approved in the EU for the treatment of symptomatic,...


(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that its Koselugo asset has been approved for usage in the European Union for the rare, progr...


(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:


(Alliance News) - AstraZeneca PLC on Wednesday said its drug Tezspire has been approved in the European Union for the treatment of adult patients with...